Surgical treatment for hepatocellular carcinoma

Saudi Journal of Gastroenterology

Volumn 21, Issue 1, 2015, Pages 11-17

  Madkhali, Ahmad A ^a,b   Fadel, Zahir T ^b,c   Aljiffry, Murad M ^c   Hassanain, Mazen M ^a,b  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b MCGILL UNIVERSITY   (Canada)

^c King Abdulaziz University   (Saudi Arabia)

Author keywords

Bridging therapy; downsizing; hepatocellular carcinoma; liver; liver malignant tumor; liver resection; liver transplantation; transarterial chemoembolization

Indexed keywords

ARTIFICIAL EMBOLISM; CANCER EPIDEMIOLOGY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CHEMOEMBOLIZATION; CHILD PUGH SCORE; COMPARATIVE EFFECTIVENESS; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FUNCTION; LIVER RESECTION; LIVER TRANSPLANTATION; LYMPH NODE METASTASIS; MULTIMODALITY CANCER THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; PREOPERATIVE EVALUATION; REVIEW; TREATMENT OUTCOME; TREATMENT RESPONSE; CARCINOMA, HEPATOCELLULAR; LIVER NEOPLASMS; PROCEDURES;

CARCINOMA, HEPATOCELLULAR; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION;

EID: 84923338005     PISSN: 13193767     EISSN: 19984049     Source Type: Journal    
DOI: 10.4103/1319-3767.151216     Document Type: Review

References (66)

1. Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol 2001;2:533-43
2. Kuntz E. Malignant liver tumor. Hepatology Textbook and Atlas: History, Part 4. Springer: Heidelberg; 2008. p. 795-835
3. Oliver JH 3rd, Baron RL, Federle MP, Rockette HE Jr. Detecting hepatocellular carcinoma: Value of unenhanced or arterial phase CT imaging or both used in conjunction with conventional portal venous phase contrast-enhanced CT imaging. AJR Am J Roentgenol 1996;167:71-7
4. Baron RL, Oliver JH 3rd, Dodd GD 3rd, Nalesnik M, Holbert BL, Carr B. Hepatocellular carcinoma: Evaluation with biphasic, contrast-enhanced, helical CT. Radiology 1996;199:505-11
5. Dodd GD 3rd, Baron RL, Oliver JH 3rd, Federle MP, Baumgartel PB. Enlarged abdominal lymph nodes in end-stage cirrhosis: CT-histopathologic correlation in 507 patients. Radiology 1997;203:127-30
6. Grobmyer SR, Wang L, Gonen M, Fong Y, Klimstra D, DAngelica M, et al. Perihepatic lymph node assessment in patients undergoing partial hepatectomy for malignancy. Ann Surg 2006;244:260-4
7. Hepatobiliary Cancers National comprehensive cancer network 2012. Available from: http://www.nccn.org. [Last accessed on 2014 Jan 5
8. Molmenti EP, Klintmalm GB. Liver transplantation in association with hepatocellular carcinoma: An update of the International Tumor Registry. Liver Transpl 2002;8:736-48
9. Bruix J, Castells A, Bosch J, Feu F, Fuster J, Garcia-Pagan JC, et al. Surgical resection of hepatocellular carcinoma in cirrhotic patients: Prognostic value of preoperative portal pressure. Gastroenterology 1996;111:1018-22
10. Schroeder RA, Marroquin CE, Bute BP, Khuri S, Henderson WG, Kuo PC. Predictive indices of morbidity and mortality after liver resection. Ann Surg 2006;243:373-9
11. Surgical resection for hepatocellular carcinoma, Up to date [Internet]. 2012. Available from: http://www.uptodate.com [Last accessed on 2012
12. Llovet JM, Fuster J, Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: Resection versus transplantation. Hepatology 1999;30:1434-40
13. Clavien PA, Petrowsky H, DeOliveira ML, Graf R. Strategies for safer liver surgery and partial liver transplantation. N Engl J Med 2007;356:1545-59
14. Lau H, Man K, Fan ST, Yu WC, Lo CM, Wong J. Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomy. Br J Surg 1997;84:1255-9
15. Imamura H, Sano K, Sugawara Y, Kokudo N, Makuuchi M. Assessment of hepatic reserve for indication of hepatic resection: Decision tree incorporating indocyanine green test. J Hepatobiliary Pancreat Surg 2005;12:16-22
16. Poon RT, Fan ST. Assessment of hepatic reserve for indication of hepatic resection: How I do it. J Hepatobiliary Pancreatic Surg 2005;12:31-7
17. Abulkhir A, Limongelli P, Healey AJ, Damrah O, Tait P, Jackson J, et al. Preoperative portal vein embolization for major liver resection: A meta-analysis. Ann Surg 2008;247:49-57
18. Imamura H, Shimada R, Kubota M, Matsuyama Y, Nakayama A, Miyagawa S, et al. Preoperative portal vein embolization: An audit of 84 patients. Hepatology 1999;29:1099-105
19. Yoo H, Kim JH, Ko GY, Kim KW, Gwon DI, Lee SG, et al. Sequential transcatheter arterial chemoembolization and portal vein embolization versus portal vein embolization only before major hepatectomy for patients with hepatocellular carcinoma. Ann Surg oncol 2011;18:1251-7
20. Farges O, Belghiti J, Kianmanesh R, Regimbeau JM, Santoro R, Vilgrain V, et al. Portal vein embolization before right hepatectomy: Prospective clinical trial. Ann Surg 2003;237:208-17
21. Abdalla EK, Hicks ME, Vauthey JN. Portal vein embolization: Rationale, technique and future prospects. Br J Surg 2001;88:165-75
22. Ogata S, Belghiti J, Farges O, Varma D, Sibert A, Vilgrain V. Sequential arterial and portal vein embolizations before right hepatectomy in patients with cirrhosis and hepatocellular carcinoma. Br J Surg 2006;93:1091-8
23. Aoki T, Imamura H, Hasegawa K, Matsukura A, Sano K, Sugawara Y, et al. Sequential preoperative arterial and portal venous embolizations in patients with hepatocellular carcinoma. Arch Surg 2004;139:766-74
24. Zarrinpar A, Kaldas F, Busuttil RW. Liver transplantation for hepatocellular carcinoma: An update. Hepatobiliary Pancreat Dis Int 2011;10:234-42
25. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996;334:693-9
26. Adam R, Bhangui P, Vibert E, Azoulay D, Pelletier G, Duclos-Vallee JC, et al. Resection or transplantation for early hepatocellular carcinoma in a cirrhotic liver: Does size define the best oncological strategy?. Ann Surg 2012;256:883-91
27. Rahman A, Assifi MM, Pedroso FE, Maley WR, Sola JE, Lavu H, et al. Is resection equivalent to transplantation for early cirrhotic patients with hepatocellular carcinoma?. A meta-analysis. J Gastrointest Surg 2012;16:1897-909
28. Jarnagin WR. Management of small hepatocellular carcinoma: A review of transplantation, resection, and ablation. Ann Surg Oncol 2010;17:1226-33
29. Truty MJ, Vauthey JN. Surgical resection of high-risk hepatocellular carcinoma: Patient selection, preoperative considerations, and operative technique. Ann Surg Oncol 2010;17:1219-25
30. Tsai TJ, Chau GY, Lui WY, Tsay SH, King KL, Loong CC, et al. Clinical significance of microscopic tumor venous invasion in patients with resectable hepatocellular carcinoma. Surg 2000;127:603-8
31. Pawlik TM, Delman KA, Vauthey JN, Nagorney DM, Ng IO, Ikai I, et al. Tumor size predicts vascular invasion and histologic grade: Implications for selection of surgical treatment for hepatocellular carcinoma. Liver Transpl 2005;11:1086-92
32. Jonas S, Bechstein WO, Steinmüller T, Herrmann M, Radke C, Berg T, et al. Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology 2001;33:1080-6
33. Abdalla EK, Denys A, Hasegawa K, Leung TW, Makuuchi M, Murthy R, et al. Treatment of large and advanced hepatocellular carcinoma. Ann Surg Oncol 2008;15:979-85
34. Vauthey JN, Lauwers GY, Esnaola NF, Do KA, Belghiti J, Mirza N, et al. Simplified staging for hepatocellular carcinoma. J Clin Oncol 2002;20:1527-36
35. Ichikawa T, Federle MP, Grazioli L, Marsh W. Fibrolamellar Hepatocellular Carcinoma: Pre-and Posttherapy Evaluation with CT and MR Imaging 1. Radiology 2000;217:145-51
36. Meriggi F, Forni E. Surgical therapy of hepatic fibrolamellar carcinoma. Ann Ital Chir 2007;78:53-8
37. Lo CM, Lai EC, Liu CL, Fan ST, Wong J. Laparoscopy and laparoscopic ultrasonography avoid exploratory laparotomy in patients with hepatocellular carcinoma. Ann Surg 1998;227:527-32
38. Regimbeau JM, Kianmanesh R, Farges O, Dondero F, Sauvanet A, Belghiti J. Extent of liver resection influences the outcome in patients with cirrhosis and small hepatocellular carcinoma. Surg 2002;131:311-7
39. Tsuzuki T, Ogata Y, Iida S, Shimazu M. Hepatic resection in 125 patients. Archives Surg 1984;119:1025
40. Ringe B, Pichlmayr R, Wittekind C, Tusch G. Surgical treatment of hepatocellular carcinoma: Experience with liver resection and transplantation in 198 patients. World J Surg 1991;15:270-85
41. Bozzetti F, Gennari L, Regalia E, Bignami P, Montalto F, Mazzaferro V, et al. Morbidity and mortality after surgical resection of liver tumors. Analysis of 229 cases. Hepatogastroenterology 1992;39:237-41
42. Nagomey DM, van Heerden JA, Ilstrup DM, Adson MA. Primary hepatic malignancy: Surgical management and determinants of survival. Surgery 1989;106:740-8
43. Bruix J, Sherman M; American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: An update. Hepatology 2011;53:1020-2
44. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001;33:464-70
45. Freeman RB, Wiesner RH, Edwards E, Harper A, Merion R, Wolfe R. Results of the first year of the new liver allocation plan. Liver Transpl 2004;10:7-15
46. Abrams P, Marsh JW. Current approach to hepatocellular carcinoma. Surg Clin North Am 2010;90:803-16
47. Bruix J, Fuster J, Llovet JM. Liver transplantation for hepatocellular carcinoma: Foucault pendulum versus evidence-based decision. Liver Transpl 2003;9:700-2
48. Yao FY, Ferrell L, Bass NM, Watson JJ, Bacchetti P, Venook A, et al. Liver transplantation for hepatocellular carcinoma: Expansion of the tumor size limits does not adversely impact survival. Hepatology 2001;33:1394-403
49. Toso C, Trotter J, Wei A, Bigam DL, Shah S, Lancaster J, et al. Total tumor volume predicts risk of recurrence following liver transplantation in patients with hepatocellular carcinoma. Liver Transpl 2008;14:1107-15
50. Yao FY, Bass NM, Nikolai B, Merriman R, Davern TJ, Kerlan R, et al. A follow-up analysis of the pattern and predictors of dropout from the waiting list for liver transplantation in patients with hepatocellular carcinoma: Implications for the current organ allocation policy. Liver Transpl 2003;9:684-92
51. Clavien PA, Lesurtel M, Bossuyt PM, Gores GJ, Langer B, Perrier A. Recommendations for liver transplantation for hepatocellular carcinoma: An international consensus conference report. Lancet Oncol 2012;13:e11-22
52. Fujiki M, Aucejo F, Kim R. General overview of neo-adjuvant therapy for hepatocellular carcinoma before liver transplantation: Necessity or option?. Liver Int 2011;31:1081-9
53. Hwang S, Lee SG, Belghiti J. Liver transplantation for HCC: Its role. J Hepatobiliary Pancreat Sci 2010;17:443-8
54. Lesurtel M, Müllhaupt B, Pestalozzi BC, Pfammatter T, Clavien PA. Transarterial chemoembolization as a bridge to liver transplantation for hepatocellular carcinoma: An evidence-based analysis. Am J Transplant 2006;6:2644-50
55. Lu DS, Yu NC, Raman SS, Lassman C, Tong MJ, Britten C, et al. Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation. Hepatology 2005;41:1130-7
56. Cheow P, Al-Alwan A, Kachura J, Ho C, Grant D, Catiral M, et al., editors. Ablation of hepatoma as a bridge to liver transplantation reduces drop-out from prolonged waiting time. Hepatology. 111 River St, Hoboken, NJ, USA: John Wiley and Sons Inc; 2005
57. Belghiti J, Carr BI, Greig PD, Lencioni R, Poon RT. Treatment before liver transplantation for HCC. Ann Surg Oncol 2008;15:993-1000
58. Adam R, Azoulay D, Castaing D, Eshkenazy R, Pascal G, Hashizume K, et al. Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: A reasonable strategy?. Ann Surg 2003;238:508-18
59. Vivarelli M, Bellusci R, Cucchetti A, Cavrini G, De Ruvo N, Aden AA, et al. Low recurrence rate of hepatocellular carcinoma after liver transplantation: Better patient selection or lower immunosuppression?. Transplantation 2002;74:1746-51
60. Vivarelli M, Cucchetti A, Piscaglia F, La Barba G, Bolondi L, Cavallari A, et al. Analysis of risk factors for tumor recurrence after liver transplantation for hepatocellular carcinoma: Key role of immunosuppression. Liver Transpl 2005;11:497-503
61. Zhou S, Tan C, Dai Z, Zhu H, Xu M, Zhou Z, et al. Tacrolimus enhances the invasion potential of hepatocellular carcinoma cells and promotes lymphatic metastasis in a rat model of hepatocellular carcinoma: Involvement of vascular endothelial growth factor C. Transplant Proc 2011;43:2747-54
62. Menon KV, Hakeem AR, Heaton ND. Meta-analysis: Recurrence and survival following the use of sirolimus in liver transplantation for hepatocellular carcinoma. Aliment Pharmacol Ther 2013;37:411-9
63. Benson AB 3rd, Abrams TA, Ben-Josef E, Bloomston PM, Botha JF, Clary BM, et al. NCCN clinical practice guidelines in oncology: Hepatobiliary cancers. J Natl Compr Canc Netw 2009;7:350-91
64. Torzilli G, Makuuchi M, Inoue K, Takayama T, Sakamoto Y, Sugawara Y, et al. No-mortality liver resection for hepatocellular carcinoma in cirrhotic and noncirrhotic patients: Is there a way?. A prospective analysis of our approach. Arch Surg 1999;134:984-92
65. Poon RT, Fan ST, Ng IO, Lo CM, Liu CL, Wong J. Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer 2000;89:500-7
66. Duffy JP, Vardanian A, Benjamin E, Watson M, Farmer DG, Ghobrial RM, et al. Liver transplantation criteria for hepatocellular carcinoma should be expanded: A 22-year experience with 467 patients at UCLA. Ann Surg 2007;246:502-9